A cellular calculus for signal integration by T cells

Nature Immunology

Volumn 1, Issue 3, 2000, Pages 239-244

  Gett, Amanda V ^a,b   Hodgkin, Philip D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

5 (6) CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; 5-(6)-CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; FLUORESCEIN DERIVATIVE; FLUORESCENT DYE; SUCCINIMIDE DERIVATIVE;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL COUNT; CELL DIVISION; FEMALE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE; NORMAL DISTRIBUTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; CELL COUNT; CELL DIVISION; FEMALE; FLUORESCEINS; FLUORESCENT DYES; LYMPHOCYTE ACTIVATION; MICE; MODELS, IMMUNOLOGICAL; NORMAL DISTRIBUTION; SIGNAL TRANSDUCTION; SUCCINIMIDES; T-LYMPHOCYTES;

EID: 0034280834     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/79782     Document Type: Article

References (48)

1. Chambers, C.A. & Allison, J.P. Co-stimulation in T cell responses. Curr. Opin. Immunol. 9, 396-404 (1997).
2. Sperling, A.I. & Bluestone, J.A. The complexities of T-cell co-stimulation: CD28 and beyond. Immunol. Rev. 153, 155-82 (1996).
3. Grewal, I.S. & Flavell, R.A. The role of CD40 ligand in costimulation and T-cell activation. Immunol. Rev. 153, 85-106 (1996).
4. Janeway, C.A. Jr & Bottomly, K. Signals and signs for lymphocyte responses. Cell 76, 275-85 (1994).
5. Bachmann, M.F. et al. Distinct roles for LFA-I and CD28 during activation of naïve T cells: adhesion versus costimulation. Immunity 7, 549-57 (1997).
6. Cantrell, D.A. & Smith, K.A. The interleukin-2T-cell system: a new cell growth model. Science 224, 1312-1316 (1984).
7. Smith, K.A. Interleukin-2: inception, impact, and implications. Science 240, 1169-1176 (1988).
8. H2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173 (1989).
9. Swain, S.L., Weinberg, A.D., English, M. & Huston, G. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145, 3796-3806 (1990).
10. + T cells. Annu. Rev. Immunol. 12, 635-73 (1994).
11. Weiss, A. & Littman, D. R. Signal transduction by lymphocyte antigen receptors. Cell 76, 263-74 (1994).
12. Lyons, A. B. & Parish, C. R. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171, 131-137 (1994).
13. Gett, A.V. & Hodgkin, P. D. Cell division regulates the T cell cytokine repertoire, revealing a mechanism underlying immune class regulation. Proc. Natl. Acad. Sci. USA 95, 9488-93 (1998).
14. Viola, A. & Lanzavecchia, A. T cell activation determined by T cell receptor number and tunable thresholds. Science 273, 104-6 (1996).
15. Iezzi, G., Karjalainen, K. & Lanzavecchia, A. The duration of antigenic stimulation determines the fate of naïve and effector T cells. Immunity 8, 89-95 (1998).
16. Germann, T. et al. Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type I (Th1) but not on Th2 cells. Eur. J. Immunol. 23, 1762-70 (1993).
17. + T cells from human immunodeficiency virus-infected persons. J. Exp. Med. 182, 1759-67 (1995).
18. Trinchieri, G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13, 251-76 (1995).
19. Brown, M., Hu-Li, J. & Paul, W. E. IL-4/B cell stimulatory factor I stimulates T cell growth by an IL-2-independent mechanism. J. Immunol. 141, 504-11 (1988).
20. Fernandez-Botran, R., Sanders, V. M., Mosmann, T. R. & Vitetta, E. S. Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells. J. Exp. Med. 168, 543-58 (1988).
21. Pfeiffer, C. et al. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181, 1569-1574 (1995).
22. Mitchell, L. C., Davis, L. S. & Lipsky, P. E. Promotion of human T lymphocyte proliferation by IL-4. J. Immunol. 142, 1548-1557 (1989).
23. + T cells. J. Immunol. 163, 1817-1826 (1999).
24. Vella, A., Teague, T. K., Ihle, J., Kappler, J. & Marrack, P. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: Stat6 is probably not required for the effect of IL-4. J. Exp. Med. 186, 325-330 (1997).
25. Lenardo, M.J. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353, 858-61 (1991).
26. Russell, J. H., White. C. L., Loh, D.Y. & Meleedy-Rey, P. Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc. Natl. Acad Sci. USA 88, 2151-5 (1991).
27. Brunner, T. et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373, 441-4 (1995).
28. Dhein, J., Walczak, H., Baumler, C., Debatin, K. M. & Krammer, P. H. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373, 438-41 (1995).
29. Boise, L. H. et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xl. Immunity 3, 87-98 (1995).
30. Sperling, A. I. et al. CD28/B7 interactions deliver a unique signal to naïve T cells that regulates cell survival but not early proliferation. J. Immunol. 157, 3909-17 (1996).
31. Lafferty, K.J. & Cunningham, A.J. A new analysis of allogeneic interactions. Aust. J. Exp. Biol. Med. Sci. 53, 27-42 (1975).
32. Lafferty, K. J., Prowse, S. J., Simeonovic, C. J. & Warren, H. S. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu. Rev. Immunol. 1, 143-73 (1983).
33. Green, J.M. et al. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1, 501-508 (1994).
34. Shahinian, A. et al. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261, 609-12 (1993).
35. Lindstein, T., June, C. H., Ledbetter, J.A., Stella, G. & Thompson, C. B. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244, 339-43 (1989).
36. Fraser, J. D., Irving, B. A., Crabtree, G. R. & Weiss, A. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 25, 313-316 (1991).
37. Seder, R. A., Germain, R. N., Linsley, P. S. & Paul, W. E. CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon γ production. J. Exp. Med. 179, 299-304 (1994).
38. Bretscher, P. & Cohn, M. A theory of self-nonself discrimination. Science 169, 1042-1049 (1970).
39. Bretscher, P.A. A two-step, two-signal model for the primary activation of precursor helper T cells. Proc. Natl. Acad. Sci. USA 96, 185-90 (1999).
40. Mueller, D. L., Jenkins, M. K. & Schwartz, R. H. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7, 445-80 (1989).
41. Schwartz, R. H. Models of T cell anergy: is there a common molecular mechanism? J. Exp. Med. 184, 1-8 (1996).
42. Krummel, M. F. & Allison, J. P. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182, 459-65 (1995).
43. Krummel, M. F. & Allison, J. P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183, 2533-40 (1996).
44. Walunas, T. L. et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-13 (1994).
45. Leo, O., Foo, M., Sachs, D.H., Samelson, L.E. & Bluestone, J.A. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84, 1374-1378 (1987).
46. Harding, F.A., McArthur, J., Gross, J.A., Raulet, D. & Allison, J. P. CD28 mediated signalling costimulated murine T cells and prevents induction of anergy in T cell clones. Nature 356, 607-609 (1992).
47. Hasbold, J. et al. Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester. Immunol. Cell Biol. 77, 516-522 (1999).
48. Hodgkin, P.D., Lee, J. H. & Lyons, A. B. B cell differentiation and isotype switching is related to division cycle number. J. Exp. Med. 184, 277-281 (1996).